 <h1>Pyrazinamide Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to pyrazinamide: oral tablet</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, pyrazinamide may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking pyrazinamide:</p><p>
<i>More common</i>
</p><ul>
<li>Pain in large and small joints</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Loss of appetite</li>
<li>pain and swelling of joints, especially big toe, ankle, and knee</li>
<li> tense, hot skin over affected joints</li>
<li>unusual tiredness or weakness</li>
<li>yellow eyes or skin</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of pyrazinamide may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Rare</i>
</p><ul>
<li>Itching</li>
<li>skin rash</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to pyrazinamide: oral tablet</i></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Mild arthralgia, myalgia</p>
<p><b>Frequency not reported</b>: Arthralgia<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Rare</b> (0.01% to 0.1%): Adverse effects on blood clotting mechanisms, erythrocyte vacuolation, sideroblastic anemia, thrombocytopenia</p>
<p><b>Frequency not reported</b>: Splenomegaly<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Rare</b> (0.01% to 0.1%): Increased serum iron concentration, porphyria</p>
<p><b>Frequency not reported</b>: Anorexia, gout/active gout<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Rare</b> (0.01% to 0.1%): Acne, photosensitivity</p>
<p><b>Frequency not reported</b>: Pruritus, rashes, urticaria<sup>[Ref]</sup></p><h3>Other</h3><p><b>Rare</b> (0.01% to 0.1%): Fever</p>
<p><b>Frequency not reported</b>: Malaise<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Rare</b> (0.01% to 0.1%): Dysuria<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Rare</b> (0.01% to 0.1%): Interstitial nephritis<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Rare</b> (0.01% to 0.1%): Erythroid hyperplasia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Clinical jaundice, hepatic failure/fatal hepatic failure, hepatic reaction, hepatomegaly, hepatotoxicity, liver tenderness, symptomless abnormality of hepatic cell function<sup>[Ref]</sup></p><p>Hepatotoxicity may be dose-related, and can occur at any time during treatment.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Frequency not reported</b>: Aggravation of peptic ulcer, nausea, vomiting<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Hypersensitivity reactions<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Frequency not reported</b>: Flushing<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Pyrazinamide (pyrazinamide)." VersaPharm Inc, Marietta, GA. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p></div>
<div class="more-resources" id="moreResources">
<h2>More about pyrazinamide</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Drug class: miscellaneous antituberculosis agents</li>
<li>FDA Alerts (1)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Pyrazinamide &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Tuberculosis, Active</li>
<li>Tuberculosis, Latent</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to pyrazinamide: oral tablet</i></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Mild arthralgia, myalgia</p><p><b>Frequency not reported</b>: Arthralgia<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Rare</b> (0.01% to 0.1%): Adverse effects on blood clotting mechanisms, erythrocyte vacuolation, sideroblastic anemia, thrombocytopenia</p><p><b>Frequency not reported</b>: Splenomegaly<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Rare</b> (0.01% to 0.1%): Increased serum iron concentration, porphyria</p><p><b>Frequency not reported</b>: Anorexia, gout/active gout<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Rare</b> (0.01% to 0.1%): Acne, photosensitivity</p><p><b>Frequency not reported</b>: Pruritus, rashes, urticaria<sup>[Ref]</sup></p><h3>Other</h3><p><b>Rare</b> (0.01% to 0.1%): Fever</p><p><b>Frequency not reported</b>: Malaise<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Rare</b> (0.01% to 0.1%): Dysuria<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Rare</b> (0.01% to 0.1%): Interstitial nephritis<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Rare</b> (0.01% to 0.1%): Erythroid hyperplasia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Clinical jaundice, hepatic failure/fatal hepatic failure, hepatic reaction, hepatomegaly, hepatotoxicity, liver tenderness, symptomless abnormality of hepatic cell function<sup>[Ref]</sup></p><p>Hepatotoxicity may be dose-related, and can occur at any time during treatment.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Frequency not reported</b>: Aggravation of peptic ulcer, nausea, vomiting<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Hypersensitivity reactions<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Frequency not reported</b>: Flushing<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Pyrazinamide (pyrazinamide)." VersaPharm Inc, Marietta, GA. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><h2>More about pyrazinamide</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Drug class: miscellaneous antituberculosis agents</li>
<li>FDA Alerts (1)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Pyrazinamide &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Tuberculosis, Active</li>
<li>Tuberculosis, Latent</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>